Approvals/TGA/APLIDIN plitidepsin 2 mg powder for solution for infusion; vial (2 mg powder) and ampoule (4 mL solution)

Approved

STANDARD

APLIDIN plitidepsin 2 mg powder for solution for infusion; vial (2 mg powder) and ampoule (4 mL solution)

Specialised Therapeutics Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2cb62f4fe1681baf
Product Name: APLIDIN plitidepsin 2 mg powder for solution for infusion; vial (2 mg powder) and ampoule (4 mL solution)
Artg Id: 291661
Artg Name: APLIDIN plitidepsin 2 mg powder for infusion vial and diluent ampoule composite pack
Sponsor: Specialised Therapeutics Pharma Pty Ltd
Company Detail Path: /organization/specialised-therapeutics-pharma-pty-ltd
Artg Date: 2018-12-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c57870ea38753a273f29dea168d22c0a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f3355c55be9b8637323d6d20834de42f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2cb62f4fe1681baf

Type

Standard